Skip to main content

Nixon Peabody LLP

  • People
  • Capabilities
  • Insights
  • About
Trending Topics
    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni
    Practices

    View All

    • Affordable Housing
    • Community Development Finance
    • Corporate & Finance
    • Cybersecurity & Privacy
    • Entertainment & Media
    • Environmental
    • Franchising & Distribution
    • Government Investigations & White Collar Defense
    • Healthcare
    • Intellectual Property
    • International Services
    • Labor, Employment, and Benefits
    • Litigation
    • Private Wealth & Advisory
    • Project Finance
    • Public Finance
    • Real Estate
    • Regulatory & Government Relations
    Industries

    View All

    • Aviation
    • Cannabis
    • Consumer
    • Energy
    • Financial Services
    • Healthcare
    • Higher Education
    • Infrastructure
    • Manufacturing
    • Nonprofit Organizations
    • Real Estate
    • Sports & Stadiums
    • Technology
    Value-Added Services

    View All

    • Alternative Fee Arrangements

      Developing innovative pricing structures and alternative fee agreement models that deliver additional value for our clients.

    • Continuing Education

      Advancing professional knowledge and offering credits for attorneys, staff and other professionals.

    • Crisis Advisory

      Helping clients respond correctly when a crisis occurs.

    • DEI Strategic Services

      Providing our clients with legal, strategic, and practical advice to make transformational changes in their organizations.

    • eDiscovery

      Leveraging law and technology to deliver sound solutions.

    • Environmental, Social, and Governance (ESG)

      We help clients create positive return on investments in people, products, and the planet.

    • Global Services

      Delivering seamless service through partnerships across the globe.

    • Innovation

      Leveraging leading-edge technology to guide change and create seamless, collaborative experiences for clients and attorneys.

    • IPED

      Industry-leading conferences focused on affordable housing, tax credits, and more.

    • Legal Project Management

      Providing actionable information to support strategic decision-making.

    • Legally Green

      Teaming with clients to advance sustainable projects, mitigate the effects of climate change, and protect our planet.

    • Nixon Peabody Trust Company

      Offering a range of investment management and fiduciary services.

    • NP Capital Connector

      Bringing together companies and investors for tomorrow’s new deals.

    • NP Second Opinion

      Offering fresh insights on cases that are delayed, over budget, or off-target from the desired resolution.

    • NP Trial

      Courtroom-ready lawyers who can resolve disputes early on clients’ terms or prevail at trial before a judge or jury.

    • Social Impact

      Creating positive impact in our communities through increasing equity, access, and opportunity.

    • Women in Dealmaking

      We provide strategic counsel on complex corporate transactions and unite dynamic women in the dealmaking arena.

    1. Home
    2. Capabilities
    3. Practices
    4. Life Sciences

      Practices

    Healthcare and Life Sciences

    In the ever-evolving landscape of healthcare and life sciences industry, we recognize the seismic shifts taking place. As a dedicated healthcare and life sciences law firm, our experienced team is dedicated to helping you transform the challenges faced by the healthcare and life science industry today into opportunities of tomorrow.

    /Overview

    Digital enablement, decentralized clinical trials, and evolving drug-pricing models are among the forces driving this rapid transformation. Nixon Peabody’s Life Sciences team is ready to guide you through this complex and fast-moving environment.

    Our life sciences attorneys and professionals hold doctorates in biological, chemical, and pharmacological sciences. We partner with leading research universities and large public companies while also helping start-ups scale and thrive.

    We help clients structure new business models, navigate regulatory matters, as well as protect and commercialize intellectual property. As a trusted life sciences law firm, we serve as an extension of your team when it matters most. Our experience, creativity, and skill can help you turn today’s life sciences challenges into tomorrow’s opportunities.

    /Representative experience

    • CMTx Biotech: Represented a clinical-stage biopharmaceutical company in an exclusive, worldwide license agreement with Galderma Holdings to develop and commercialize incyclinide, a clinical-stage, orally administered small molecule drug candidate for the treatment of hospitalized COVID-19 patients, among other potential therapeutic indications
    • Emmaus Medical, Inc.: Represented a specialty pharma company focused on rare and orphan diseases in clinical research matters; international pharmaceutical manufacturing, distribution, and compassionate-use transactions; a collaboration with Kainos Medicine, Inc. for preclinical development of IRAK4 inhibitor as a potential anti-cancer drug; and a series of research and licensing transactions with The Lundquist Institute
    • Merck KGaA: Represented one of the largest pharmaceutical companies in the world in numerous corporate transactions and strategic investments
    • Sciformix Corporation: Represented a scientific services company within the biopharmaceutical field in its sale to Covance Asia-Pacific Inc., a subsidiary of Laboratory Corporation of America Holdings
    • Seattle Children’s Hospital: Represented a children’s hospital in a licensing and clinical research collaboration with Cellevolve Bio to develop and commercialize a suite of novel multiplex CARs for the treatment of pediatric CNS malignancies. The cell therapy products are produced in Seattle Children’s GMP facilities and are already in clinical trials
    • Serimmune Inc.: Serve as outside counsel to an immune intelligence company developing new approaches for preventing, diagnosing, and treating a range of diseases
    • UC Santa Barbara: Represented a university technology transfer office in several iterations of negotiations with one of its biotech spinoffs. This work included restructuring UC Santa Barbara’s equity and license relationship with the company to address the complexities of the company’s sublicensing partnerships with numerous pharmaceutical companies
    • Large pharmaceutical company: Lead counsel in an expedited trial in Delaware Chancery Court claiming fraud against defendant (a biotech company). Following a six-day bench trial, the court found in our client’s favor and later awarded over $49 million in damages and pre-judgment interest to our client.

    /Recognition

    • Nixon Peabody has been named a Tier 1 National firm for Health Care Law and Patent Law in the 2025 edition of Best Law Firms®.

    Our Team

    See Full Team
    • Seth D. Levy

      Partner / Leader, Intellectual Property Practice
      • Los Angeles
      • Office:+1 213.629.6161
      • slevy@nixonpeabody.com
      Seth D. Levy
    • Jill H. Gordon

      Partner / Co-chair, Life Sciences Practice
      • Los Angeles
      • Office:+1 213.629.6175
      • jgordon@nixonpeabody.com
      Jill H. Gordon
    • Hannah Bornstein

      Partner / Deputy Practice Group Leader, Government Investigations & White Collar Defense
      • Boston
      • Office:+1 617.345.1217
      • hbornstein@nixonpeabody.com
      Hannah Bornstein
    • Allan H. Cohen

      Partner / Office Managing Partner, Long Island
      • Long Island
      • Office:+1 516.832.7522
      • acohen@nixonpeabody.com
      Allan H. Cohen
    • Christopher P. Keefe

      Partner / Chair, Business & Finance Department
      • Boston
      • Office:+1 617.345.1350
      • ckeefe@nixonpeabody.com
      Christopher P. Keefe
    • Jason Chimon

      Partner / Co-Lead, Accelerators & Incubators IP Team
      • Long Island
      • Office:+1 516.832.7574
      • jchimon@nixonpeabody.com
      Jason Chimon
    See Full Team

    Insights And Happenings

    View All
    • Alert

      US scientists and executives under renewed scrutiny over China ties

      March 13, 2025
    • Alert

      NIH seeks reduction of research indirect cost rates to 15%

      Feb 14, 2025
    • Alert

      Trump pauses FCPA Enforcement

      Feb 11, 2025
    View All

    Subscribe to stay informed of the latest legal news, alerts, and business trends.Subscribe

    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni
    • Cookie Preferences
    • Privacy Policy
    • Terms of Use
    • Accessibility Statement
    • Statement of Client Rights
    • Purchase Order Terms & Conditions
    • Nixon Peabody International LLC
    • PAL
    © 2025 Nixon Peabody. All rights reserved